Does the media favor HNGE or PRVA?

In the previous week, Hinge Health had 6 more articles in the media than Privia Health Group. MarketBeat recorded 8 mentions for Hinge Health and 2 mentions for Privia Health Group. Hinge Health's average media sentiment score of 1.45 beat Privia Health Group's score of 1.33 indicating that Hinge Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hinge Health 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Privia Health Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, PRVA or CHE?

Chemed has higher revenue and earnings than Privia Health Group. Chemed is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Privia Health Group $2.12B 1.23 $22.92M $0.21 97.24 Chemed $2.53B 2.66 $265.24M $19.91 25.87

Does the media favor PRVA or CHE?

In the previous week, Chemed had 8 more articles in the media than Privia Health Group. MarketBeat recorded 10 mentions for Chemed and 2 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.33 beat Chemed's score of 1.04 indicating that Privia Health Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Privia Health Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Chemed 6 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer HIMS or PRVA?

In the previous week, Hims & Hers Health had 32 more articles in the media than Privia Health Group. MarketBeat recorded 34 mentions for Hims & Hers Health and 2 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.33 beat Hims & Hers Health's score of 0.18 indicating that Privia Health Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 4 Very Positive mention(s) 6 Positive mention(s) 22 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Privia Health Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor RDNT or PRVA?

In the previous week, RadNet had 6 more articles in the media than Privia Health Group. MarketBeat recorded 8 mentions for RadNet and 2 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.33 beat RadNet's score of 0.84 indicating that Privia Health Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Privia Health Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to PRVA or LFST?

In the previous week, LifeStance Health Group had 16 more articles in the media than Privia Health Group. MarketBeat recorded 18 mentions for LifeStance Health Group and 2 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.33 beat LifeStance Health Group's score of 0.85 indicating that Privia Health Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Privia Health Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LifeStance Health Group 8 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Privia Health Group (PRVA) Competitors

$20.42 +0.05 (+0.25%)

Closing price 04:00 PM Eastern

Extended Trading

$20.43 +0.01 (+0.05%)

As of 07:30 PM Eastern

Compare

PRVA vs. HNGE, CHE, HIMS, RDNT, and LFST

Should you buy Privia Health Group stock or one of its competitors? Privia Health Group's main competitors and comparable companies include Hinge Health (HNGE), Chemed (CHE), Hims & Hers Health (HIMS), RadNet (RDNT), and LifeStance Health Group (LFST). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Privia Health Group compare to Hinge Health?

Hinge Health (NYSE:HNGE) and Privia Health Group (NASDAQ:PRVA) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings.

Hinge Health has a beta of 1.38, indicating that its stock price is 38% more volatile than the broader market. Comparatively, Privia Health Group has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market.

94.5% of Privia Health Group shares are owned by institutional investors. 18.9% of Hinge Health shares are owned by insiders. Comparatively, 5.7% of Privia Health Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Privia Health Group has higher revenue and earnings than Hinge Health. Hinge Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hinge Health	$587.86M	12.20	-$528.26M	$1.28	69.42
Privia Health Group	$2.12B	1.23	$22.92M	$0.21	97.24

In the previous week, Hinge Health had 6 more articles in the media than Privia Health Group. MarketBeat recorded 8 mentions for Hinge Health and 2 mentions for Privia Health Group. Hinge Health's average media sentiment score of 1.45 beat Privia Health Group's score of 1.33 indicating that Hinge Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hinge Health	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Privia Health Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hinge Health currently has a consensus target price of $101.93, suggesting a potential upside of 14.71%. Privia Health Group has a consensus target price of $31.00, suggesting a potential upside of 51.81%. Given Privia Health Group's higher probable upside, analysts plainly believe Privia Health Group is more favorable than Hinge Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hinge Health	1 Sell rating(s)	2 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.83
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

Hinge Health has a net margin of 15.15% compared to Privia Health Group's net margin of 1.19%. Hinge Health's return on equity of 51.60% beat Privia Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hinge Health	15.15%	51.60%	14.16%
Privia Health Group	1.19%	3.52%	2.00%

Summary

Hinge Health beats Privia Health Group on 12 of the 17 factors compared between the two stocks.

How does Privia Health Group compare to Chemed?

Privia Health Group (NASDAQ:PRVA) and Chemed (NYSE:CHE) are both mid-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings.

Privia Health Group presently has a consensus target price of $31.00, suggesting a potential upside of 51.81%. Chemed has a consensus target price of $530.75, suggesting a potential upside of 3.02%. Given Privia Health Group's stronger consensus rating and higher probable upside, equities analysts plainly believe Privia Health Group is more favorable than Chemed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79
Chemed	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

In the previous week, Chemed had 8 more articles in the media than Privia Health Group. MarketBeat recorded 10 mentions for Chemed and 2 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.33 beat Chemed's score of 1.04 indicating that Privia Health Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Privia Health Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Chemed	6 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

94.5% of Privia Health Group shares are owned by institutional investors. Comparatively, 95.9% of Chemed shares are owned by institutional investors. 5.7% of Privia Health Group shares are owned by company insiders. Comparatively, 3.3% of Chemed shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Chemed has higher revenue and earnings than Privia Health Group. Chemed is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Privia Health Group	$2.12B	1.23	$22.92M	$0.21	97.24
Chemed	$2.53B	2.66	$265.24M	$19.91	25.87

Chemed has a net margin of 10.60% compared to Privia Health Group's net margin of 1.19%. Chemed's return on equity of 31.77% beat Privia Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Privia Health Group	1.19%	3.52%	2.00%
Chemed	10.60%	31.77%	18.90%

Privia Health Group has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market. Comparatively, Chemed has a beta of 0.51, indicating that its stock price is 49% less volatile than the broader market.

Summary

Chemed beats Privia Health Group on 9 of the 16 factors compared between the two stocks.

How does Privia Health Group compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Privia Health Group (NASDAQ:PRVA) are both mid-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk, analyst recommendations and media sentiment.

Privia Health Group has a net margin of 1.19% compared to Hims & Hers Health's net margin of -5.51%. Privia Health Group's return on equity of 3.52% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-5.51%	-6.51%	-1.20%
Privia Health Group	1.19%	3.52%	2.00%

Hims & Hers Health presently has a consensus price target of $32.43, suggesting a potential upside of 18.18%. Privia Health Group has a consensus price target of $31.00, suggesting a potential upside of 51.81%. Given Privia Health Group's stronger consensus rating and higher probable upside, analysts plainly believe Privia Health Group is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.13
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

Hims & Hers Health has a beta of 2.42, meaning that its stock price is 142% more volatile than the broader market. Comparatively, Privia Health Group has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market.

In the previous week, Hims & Hers Health had 32 more articles in the media than Privia Health Group. MarketBeat recorded 34 mentions for Hims & Hers Health and 2 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.33 beat Hims & Hers Health's score of 0.18 indicating that Privia Health Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	4 Very Positive mention(s)	6 Positive mention(s)	22 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Privia Health Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hims & Hers Health has higher revenue and earnings than Privia Health Group. Hims & Hers Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.73	$128.37M	-$0.63	N/A
Privia Health Group	$2.12B	1.23	$22.92M	$0.21	97.24

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 94.5% of Privia Health Group shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by insiders. Comparatively, 5.7% of Privia Health Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Privia Health Group beats Hims & Hers Health on 10 of the 16 factors compared between the two stocks.

How does Privia Health Group compare to RadNet?

RadNet (NASDAQ:RDNT) and Privia Health Group (NASDAQ:PRVA) are both mid-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends.

Privia Health Group has a net margin of 1.19% compared to RadNet's net margin of -0.93%. Privia Health Group's return on equity of 3.52% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.93%	2.61%	0.91%
Privia Health Group	1.19%	3.52%	2.00%

Privia Health Group has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.91	-$18.65M	-$0.27	N/A
Privia Health Group	$2.12B	1.23	$22.92M	$0.21	97.24

RadNet has a beta of 1.41, suggesting that its stock price is 41% more volatile than the broader market. Comparatively, Privia Health Group has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market.

In the previous week, RadNet had 6 more articles in the media than Privia Health Group. MarketBeat recorded 8 mentions for RadNet and 2 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.33 beat RadNet's score of 0.84 indicating that Privia Health Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	2 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Privia Health Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

77.9% of RadNet shares are held by institutional investors. Comparatively, 94.5% of Privia Health Group shares are held by institutional investors. 5.1% of RadNet shares are held by company insiders. Comparatively, 5.7% of Privia Health Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

RadNet presently has a consensus target price of $90.00, suggesting a potential upside of 19.22%. Privia Health Group has a consensus target price of $31.00, suggesting a potential upside of 51.81%. Given Privia Health Group's higher possible upside, analysts clearly believe Privia Health Group is more favorable than RadNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.89
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

Summary

Privia Health Group beats RadNet on 12 of the 17 factors compared between the two stocks.

How does Privia Health Group compare to LifeStance Health Group?

Privia Health Group (NASDAQ:PRVA) and LifeStance Health Group (NASDAQ:LFST) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, valuation and earnings.

Privia Health Group has higher revenue and earnings than LifeStance Health Group. Privia Health Group is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Privia Health Group	$2.12B	1.23	$22.92M	$0.21	97.24
LifeStance Health Group	$1.42B	3.48	$9.66M	$0.13	99.77

LifeStance Health Group has a net margin of 3.19% compared to Privia Health Group's net margin of 1.19%. Privia Health Group's return on equity of 3.52% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Privia Health Group	1.19%	3.52%	2.00%
LifeStance Health Group	3.19%	3.39%	2.33%

94.5% of Privia Health Group shares are owned by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are owned by institutional investors. 5.7% of Privia Health Group shares are owned by company insiders. Comparatively, 3.5% of LifeStance Health Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Privia Health Group presently has a consensus price target of $31.00, suggesting a potential upside of 51.81%. LifeStance Health Group has a consensus price target of $12.88, suggesting a potential downside of 0.73%. Given Privia Health Group's stronger consensus rating and higher probable upside, research analysts clearly believe Privia Health Group is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

Privia Health Group has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.22, indicating that its stock price is 22% more volatile than the broader market.

In the previous week, LifeStance Health Group had 16 more articles in the media than Privia Health Group. MarketBeat recorded 18 mentions for LifeStance Health Group and 2 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.33 beat LifeStance Health Group's score of 0.85 indicating that Privia Health Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Privia Health Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LifeStance Health Group	8 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Privia Health Group beats LifeStance Health Group on 10 of the 17 factors compared between the two stocks.

Get Privia Health Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PRVA vs. The Competition

Export

Metric	Privia Health Group	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.60B	$9.87B	$7.16B	$12.72B
Dividend Yield	N/A	2.61%	2.56%	11.15%
P/E Ratio	97.24	33.27	272.69	25.25
Price / Sales	1.23	4.86	594.77	72.00
Price / Cash	76.33	125.76	77.04	51.44
Price / Book	3.18	5.29	10.33	6.20
Net Income	$22.92M	$313.25M	$3.49B	$358.27M
7 Day Performance	-1.16%	-1.26%	-3.29%	-2.35%
1 Month Performance	-7.10%	-0.77%	-0.26%	-2.61%
1 Year Performance	-10.87%	14.22%	17.32%	8.08%

Privia Health Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PRVA Privia Health Group	4.1862 of 5 stars	$20.42 +0.2%	$31.00 +51.8%	-10.2%	$2.60B	$2.12B	97.24	1,226	Positive News
HNGE Hinge Health	3.7528 of 5 stars	$91.61 -0.8%	$101.93 +11.3%	+57.6%	$7.40B	$720.06M	71.63	1,437	Analyst Forecast Insider Trade
CHE Chemed	4.4064 of 5 stars	$522.40 +0.5%	$530.75 +1.6%	+13.8%	$6.83B	$2.53B	26.24	15,811	Positive News
HIMS Hims & Hers Health	2.8736 of 5 stars	$27.97 +0.9%	$32.50 +16.2%	-42.5%	$6.52B	$2.35B	N/A	2,442	Trending News Analyst Forecast
RDNT RadNet	3.2103 of 5 stars	$72.62 -1.5%	$90.00 +23.9%	+4.2%	$5.72B	$2.04B	N/A	11,264

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PRVA) was last updated on 9/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Privia Health Group (PRVA) Competitors

PRVA vs. HNGE, CHE, HIMS, RDNT, and LFST

How does Privia Health Group compare to Hinge Health?

Summary

How does Privia Health Group compare to Chemed?

Summary

How does Privia Health Group compare to Hims & Hers Health?

Summary

How does Privia Health Group compare to RadNet?

Summary

How does Privia Health Group compare to LifeStance Health Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRVA vs. The Competition

Privia Health Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Privia Health Group (PRVA) Competitors

PRVA vs. HNGE, CHE, HIMS, RDNT, and LFST

How does Privia Health Group compare to Hinge Health?

Which has more risk & volatility, HNGE or PRVA?

Do insiders & institutionals hold more shares of HNGE or PRVA?

Which has stronger valuation and earnings, HNGE or PRVA?

Does the media favor HNGE or PRVA?

Do analysts prefer HNGE or PRVA?

Is HNGE or PRVA more profitable?

Summary

How does Privia Health Group compare to Chemed?

Do analysts rate PRVA or CHE?

Does the media favor PRVA or CHE?

Do insiders and institutionals hold more shares of PRVA or CHE?

Which has better earnings & valuation, PRVA or CHE?

Is PRVA or CHE more profitable?

Which has more risk and volatility, PRVA or CHE?

Summary

How does Privia Health Group compare to Hims & Hers Health?

Is HIMS or PRVA more profitable?

Do analysts rate HIMS or PRVA?

Which has more risk & volatility, HIMS or PRVA?

Does the media prefer HIMS or PRVA?

Which has stronger valuation & earnings, HIMS or PRVA?

Do insiders & institutionals have more ownership in HIMS or PRVA?

Summary

How does Privia Health Group compare to RadNet?

Is RDNT or PRVA more profitable?

Which has higher earnings & valuation, RDNT or PRVA?

Which has more volatility and risk, RDNT or PRVA?

Does the media favor RDNT or PRVA?

Do institutionals and insiders hold more shares of RDNT or PRVA?

Do analysts recommend RDNT or PRVA?

Summary

How does Privia Health Group compare to LifeStance Health Group?

Which has stronger earnings & valuation, PRVA or LFST?

Is PRVA or LFST more profitable?

Do institutionals & insiders hold more shares of PRVA or LFST?

Do analysts rate PRVA or LFST?

Which has more risk and volatility, PRVA or LFST?

Does the media refer more to PRVA or LFST?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRVA vs. The Competition

Privia Health Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools